.@CarolynBertozzi's role in pushing glycoscience forward is undeniable, but peers are quick to stress the broader impact of the scientists she’s trained. As her life gets busier, she remains dedicated to raising new generations of glyco evangelists. https://t.co/mr9ATIyrCI
Interested in #celltherapies? Here's a new collection of freely accessible reviews https://t.co/3KOylu76j2 - covering regulatory T cells for immune disorders, gamma delta T cells for cancer and engineered haematopoietic stem cells for blood disorders
Check out this job: Associate Director - Preformulation and Biopharmaceutics in Advanced Drug Delivery in Sweden. Ready to come and work with us on cool #drugdelivery ? Interesting #biopharmaceutics problems? Questions pls let me know. RTs appreciated https://t.co/lWwrPmpfMq
Human milk can be considered literally a "magic fluid". This review explores the role of glycans, abundant in milk, in shaping the development of the infant and the infant-gut microbiota via @AnnualReviews https://t.co/84wBXikZSX
Targeted protein degradation: expanding the toolbox https://t.co/Qj8VI4mnRW - a new article discussing opportunities for exploiting more of the ~600 E3 ligases when developing PROTACs
Our newest publication showcases the importance of IgG Fc glycosylation in children with unexplained recurrant respiratory infections, published in Journal of Allergy and Clinical Immunology:
https://t.co/TvgZz7jA0A
Interesting collection in @nature about the promise of RNA-based therapy https://t.co/2Y0k2ZlVPu. We're excited about these approaches for correcting mis-splicing in cancer https://t.co/nOzFB7krXc
Alectos and Merck reveal the discovery of MK-8719, the first clinical O-GlcNAcase (OGA) inhibitor as a potential treatment for tauopathies https://t.co/yI8pVtsNLD
This is the rejection letter for the work that just won the Nobel Prize. Don’t stop believing!
I should save all of mine and maybe one day some stranger will think it’s an amazing relic and tweet it...
Great to see the NIST Interlaboratory study on mAb glycomics published in MCP. This article has broken the record for the highest number of co-authors I have even taken part in to date ;) An interesting read but also unsettling to see the diversity of results.
NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods | https://t.co/MP1XAgnpLZ #proteomics
Yay yay yay! My first...first-author paper is out! A big thank you to @mtandersen_lab and all the contributors 😊
@PastelBio@MQMolSci https://t.co/cKlc2m5n3k
Adding an O-GlcNAc or "O-GlcNAc Engineering" can improve the serum stability and in vivo efficacy of therapeutic peptides. Our latest paper out in JACS with @sevakat1, Tom Gardella, Denise Wootten, Patrick Sexton, and Patsy McDonald. https://t.co/qvzdeySrjc
A perspective was written by leading scientists in the field of glycoscience and analytical chemistry on the challenges and solutions of carbohydrate sequencing. You can access this from the CarboMet website https://t.co/VGzMAIA5tY
or from JACS https://t.co/UNrpIvIS4R
For readers interested in the technology of antibody-drug conjugates such as Roche's just-approved polatuzumab vedotin, here's a comprehensive review https://t.co/AIH6zhnvBa
I’m proud to announce that @BioRender (a project my team & I have poured our hearts into for 2 yrs) has 200K+ figures by 95K+ scientists 👨🏽🔬👩🔬! We built this so you could stop struggling to make figures in PPT 🔬 Also, the base version is free, forever 💜 https://t.co/KJpyxgxeQt